Does SECUKINUMAB Cause Dysstasia? 637 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 637 reports of Dysstasia have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.4% of all adverse event reports for SECUKINUMAB.
637
Reports of Dysstasia with SECUKINUMAB
0.4%
of all SECUKINUMAB reports
15
Deaths
139
Hospitalizations
How Dangerous Is Dysstasia From SECUKINUMAB?
Of the 637 reports, 15 (2.4%) resulted in death, 139 (21.8%) required hospitalization, and 39 (6.1%) were considered life-threatening.
Is Dysstasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 637 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Dysstasia?
ADALIMUMAB (1,181)
DALFAMPRIDINE (1,128)
METHOTREXATE (739)
ETANERCEPT (602)
PREGABALIN (544)
CARBIDOPA\LEVODOPA (457)
PIMAVANSERIN (406)
TOFACITINIB (380)
DIMETHYL (352)
TERIPARATIDE (341)
Which SECUKINUMAB Alternatives Have Lower Dysstasia Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG